Snowball logo
logo
CGTX

Cognition Therapeutics Inc

CGTX NASDAQ
$1.05-$0.03  (2.78%)

Frequently asked questions

What sector does Cognition Therapeutics Inc (CGTX) operate in?

Cognition Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Cognition Therapeutics Inc (CGTX) current stock price?

As of the latest data, Cognition Therapeutics Inc stock price is $1.05, with a previous close of $1.08. Cognition Therapeutics Inc lost -$0.03 in the last trading session, representing a -2.78% loss.

What is Cognition Therapeutics Inc (CGTX) current market capitalization?

Cognition Therapeutics Inc market cap is approximately 92.69 million.

What is Cognition Therapeutics Inc (CGTX) Earnings Per Share (EPS)?

The trailing EPS is -$0.47, and the forward EPS is -$0.34.

What is Cognition Therapeutics Inc (CGTX) EBITDA?

Cognition Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.87 million.

Does Cognition Therapeutics Inc (CGTX) pay dividends?

No. Cognition Therapeutics Inc does not pay a dividend.

When is Cognition Therapeutics Inc (CGTX) next earnings report?

Cognition Therapeutics Inc is expected to release its next earnings report on March 31, 2026.

What is Cognition Therapeutics Inc (CGTX) beta (volatility) score?

Cognition Therapeutics Inc has a beta of 1.251, suggesting it is more volatile than the market.